Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 64

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 64
---
        $
        799,491

        $
        746,641

        $
        460,713

      The following data includes property, plant, and equipment by geographic area:

        (U.S. Dollars, in thousands)
         
        2024

        2023

        U.S.
         
        $
        125,541

        $
        142,727

        Italy

        9,472

        10,187

        Germany

        1,904

        3,030

        Others

        2,887

        3,116

        Total
         
        $
        139,804

        $
        159,060

17.	Acquisition-related amortization and remeasurement Acquisition-related amortization and remeasurement consists of (i) the remeasurement of any related contingent consideration arrangement, (ii) amortization related to intangible assets acquired through business combinations or asset acquisitions, and (iii) recognized costs associated with acquired IPR&D assets, which are recognized immediately upon acquisition. Components of 

F-33

acquisition-related amortization and remeasurement for the years ended December 31, 2024, 2023, and 2022, respectively, are as follows:

        Year Ended December 31,

        (U.S. Dollars, in thousands)
         
        2024

        2023

        2022

        Changes in fair value of contingent consideration
         
        $
        6,900

        $
        (2,700
        )
         
        $
        (17,200
        )

        Amortization of acquired intangibles

        17,436

        17,408

        8,196

        Acquired IPR&D

        —

        49

        1,600

        Total
         
        $
        24,336

        $
        14,757

        $
        (7,404
        )
       
      Lattus Contingent ConsiderationIn connection with the Merger, the Company assumed a contingent consideration obligation under a purchase agreement between SeaSpine and Lattus executed in December 2022. Under the terms of the agreement, the Company may be required to make installment payments at certain dates based on future net sales of Lateral Products. For additional information regarding this contingent consideration liability, see Note 12.Spinal Kinetics Contingent